A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU [fluorouracil], as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck.

Trial Profile

A Randomised Phase II Study to Investigate the Feasibility and Benefits of Combining ZD1839 and Cisplatin/5FU [fluorouracil], as Induction Therapy, in Patients With Locally and Advanced Squamous Cell Carcinoma of the Head and Neck.

Completed
Phase of Trial: Phase II

Latest Information Update: 12 May 2009

At a glance

  • Drugs Cisplatin; Fluorouracil; Gefitinib
  • Indications Head and neck cancer
  • Focus Therapeutic Use
  • Sponsors AstraZeneca
  • Most Recent Events

    • 26 Nov 2007 Status changed from in progress to completed as reported by ClinicalTrials.gov.
    • 24 Mar 2006 New trial record.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top